Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis

Targeting of estrogen receptor is commonly used as a first-line treatment for hormone-positive breast cancer patients, and is considered as a keystone of systemic cancer therapy. Likewise, HER2-targeted therapy significantly improved the survival of HER2-positive breast cancer patients, indicating t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biochemical Society transactions Jg. 48; H. 2; S. 657
1. Verfasser:	Lev, Sima
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 29.04.2020
Schlagworte:	Animals Cell Line, Tumor Cell Membrane - metabolism Drug Resistance, Neoplasm ErbB Receptors - metabolism Female Humans Molecular Targeted Therapy Oncogenes Transcriptome Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - metabolism EGFR drug resistance target therapy
ISSN:	1470-8752, 1470-8752
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!